Delivery Order SPE2DB24D2213-SPE2DB24FGVDF
Award Date
6/24/24
Potential Completion Date
7/16/24
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS medical products to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $4,711.62, is a Firm Fixed Price Delivery Order that runs through July 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The award, valued at $1,570.54, is a Firm Fixed Price Delivery Order contract with a completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS pharmaceutical products to the U.S. government. The $1,601.99 firm fixed price Delivery Order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,570.54, has a completion date of July 31, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC enables the DLA to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The single-award Indefinite Delivery Contract (IDC) has a ceiling value of $20,720.50 and a completion date of July 25, 2024. Amerisourcebergen holds a larger IDC with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This is a federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $6,407.96 firm fixed price delivery order is for the supply of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract, valued at $3,141.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 2, 2024. This award is not associated with any set-aside designation....
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $12,537.75 to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which does not have a set-aside designation, is for the supply of PROQUAD VIALS and has an ultimate completion date of August 15, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been a significant supplier of pharmaceutical products and medical supplies to various federal...
This federal contract award, valued at $3,203.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the government.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,656.31, is a delivery order for PROQUAD VIALS with an ultimate completion date of January 21, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...